Stay updated on Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 is now active, replacing v3.4.2. This change does not alter the information presented on the page.
    Difference
    0.0%
    Check dated 2026-03-12T03:01:11.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 tag and removed the previous Notice about a lapse in government funding; these are site maintenance/version updates and do not affect the study data or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:22:12.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Notice added about a lapse in government funding and NIH Clinical Center status, and the revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T10:36:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary display and updates metadata terms (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing the previous QC wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T06:19:54.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page; no substantive content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:35:18.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A consolidated Locations section is added listing study sites in California, Colorado, Florida, Massachusetts, New York, North Carolina, Ohio, Oregon, Texas, Ontario, and Quebec. Previous per-location pages were removed and the study record revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:52.000Z thumbnail image

Stay in the know with updates to Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anti-OX40 Antibody in Atopic Dermatitis Clinical Trial page.